Electrophoresis Market is predicted to reach USD 5.36 billion at a CAGR of 5.90% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Electrophoresis Market”.

The Electrophoresis market is estimated to register a CAGR of 5.90% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Electrophoresis market— Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. Inc. (US), QIAGEN N.V. (Netherlands), Lonza (Switzerland), Shimadzu Corporation (Japan), and HOEFER INC.(US).

Electrophoresis Market Highlights

The global Electrophoresis market is accounted to register a CAGR of 5.90% during the forecast period and is estimated to reach USD 5.36 billion by 2032.

Advances in life sciences research, notably in genomics, proteomics, and personalized medicine, are driving the industry, increasing demand for sophisticated analytical techniques such as electrophoresis. Furthermore, the growing frequency of chronic diseases and genetic disorders around the world emphasizes the importance of reliable diagnostic tools, which is driving market expansion. Furthermore, the growing use of electrophoresis in drug development, quality control operations, and biopharmaceutical manufacturing provides lucrative potential for market expansion. Overall, the confluence of technological breakthroughs and the growing emphasis on precision medicine are driving the electrophoresis market's rapid expansion.

Segment Analysis

The global Electrophoresis market has been segmented based on Product, application, and end user.

On the basis of Product, the market is segmented into Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, and Electrophoresis Software. The Electrophoresis Systems segment was attributed to holding the largest market share in 2023 because of ongoing technical advancements in electrophoresis equipment, which boost biomolecule separation and analysis's automation, efficiency, and accuracy. Additionally, the market is expanding due to the rising demand for electrophoresis systems in pharmaceutical, diagnostic, and research applications.

Based on application, the global Electrophoresis market has been segmented into Research Applications, Diagnostic Applications, and Quality Control & Process Validation. The Research Applications segment was expected to hold the largest market share in 2023 attributed to many factors propelling market expansion, such as the rising breadth of genomes and proteomics research, higher investments in life sciences research and development, and expanding partnerships between academic institutions and pharmaceutical companies.

On the basis of End User, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, and Other End Users. The pharmaceutical and biotechnology companies segment was attributed to holding the largest market share in 2023 driven by a number of factors that support the market's expansion, such as the increased emphasis on personalized medicine, the need for better analytical methods for drug development, and the expansion of the biopharmaceutical pipeline. The pharmaceutical and biotechnology industries employ electrophoresis methods extensively for a number of applications, such as protein analysis, nucleic acid separation, and quality control testing during the manufacturing process.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Electrophoresis Market Research Report

Regional Analysis

The global Electrophoresis market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Electrophoresis market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Electrophoresis market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Electrophoresis market comprises of Middle East, Africa, and Latin America.

North America appears as the largest region in the electrophoresis market, owing to significant investments in R&D, a well-established pharmaceutical sector, and a sophisticated healthcare infrastructure.

Europe is the second-largest area in the electrophoresis market, owing to increased government support for life sciences research, rising frequency of chronic diseases, and growing awareness of personalized treatment.

Asia-Pacific is the fastest-growing region in the electrophoresis market, thanks to rapid expansion in the pharmaceutical and biotechnology sectors, rising healthcare spending, and supporting government policies that encourage research and development.

Furthermore, the rest of the world's Electrophoresis market is divided into the Middle East, Africa, and Latin America. The rising acceptance of innovative healthcare technology, increased focus on research and development activities, and expanded collaborations with international companies in the life sciences industry are all factors contributing to the region's success.

Key Findings of the Study

• The global Electrophoresis market is expected to reach USD 5.36 billion by 2032, at a CAGR of 5.90% during the forecast period.


• Asia-Pacific is the fastest-growing area because of rapid expansion in the pharmaceutical and biotechnology sectors, increased healthcare spending, and supportive government efforts.


• Based on product, Electrophoresis Systems have the greatest market share in 2023.


• Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. Inc. (US), QIAGEN N.V. (Netherlands), Lonza (Switzerland), Shimadzu Corporation (Japan), and HOEFER INC.(US) are the key market players.